Full history for every metric is available with a Kvantra account
Key financial summary
Financials in USDTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | - | - | - | - | 0.22 | - | - |
| Operating profit | $m | 0.11 | - | |||||
| Net profit | $m | - | - | - | - | 0.09 | - | - |
| EPS reported | $ | 0.00 | - | |||||
| Operating cashflow per share | $ | 0.00 | - | |||||
| Capex per share | $ | 0.00 | - | |||||
| FCF per share | $ | 0.00 | - | |||||
| Free cash flow | $m | - | - | |||||
| Net debt | $m | 0.62 | - | |||||
| Book value equity | $m | 0.39 | - | |||||
| Book value per share | $ | 0.00 | - | |||||
| Number of shares | m | 263.57 | - | |||||
| DPS (TTM paid) | $ | 0.00 | - |
Financial summary
Financials in USDTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 19.75 | - | |||||
| P/B LTM | x | 5.32 | - | |||||
| P/S LTM | x | 9.46 | - | |||||
| P/FCF LTM | x | 0.00 | - | |||||
| EV/EBITDA LTM | x | 23.42 | - | |||||
| EV/Sales LTM | x | 12.27 | - | |||||
| Earnings Yield LTM | % | 5.06% | - | |||||
| FCF Yield | % | 0.00% | - | |||||
| Quality | ||||||||
| ROE | % | 23.95% | - | |||||
| ROIC | % | 8.84% | - | |||||
| Operating margin | % | 48.24% | - | |||||
| Gross margin | % | 50.38% | - | |||||
| FCF/Sales | % | 0.00% | - | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +369.15% | - | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | - | |||||
| Dividend Growth | % | - | - | |||||
| Payout Ratio | % | 0.00% | - | |||||
| FCF/Debt | x | - | - | |||||
| Net Debt/EBITDA | x | 5.36 | - | |||||
| EBIT/Net interest | x | 8.59 | - | |||||
| Net debt/market cap | % | 29.69% | - | |||||
| Net debt/Equity | x | 1.58 | - | |||||
| Gross debt/equity | x | 1.79 | - | |||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Star8 Corporation is an emerging enterprise focused on the development and provision of mobile communication devices and their related accessories. The company's main target demographic is the pre-paid mobile phone sector, to which it supplies handsets primarily designed for mobile email and messaging. These devices are marketed under the brand name Axiom. Star8 Corporation utilizes mobile phone distributors to reach customers across key regions including Southeast Asia, Africa, and Latin America. Originally established in 1987, the firm was formerly known as Immunis Holding Corp, undergoing a name change to Star8 Corporation in September 2010. Its corporate headquarters are located in Tsimshatsui, Hong Kong.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Not enough data to calculate KvantraRank
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Star8 Corporation is an emerging enterprise focused on the development and provision of mobile communication devices and their related accessories. The company's main target demographic is the pre-paid mobile phone sector, to which it supplies handsets primarily designed for mobile email and messaging. These devices are marketed under the brand name Axiom. Star8 Corporation utilizes mobile phone distributors to reach customers across key regions including Southeast Asia, Africa, and Latin America. Originally established in 1987, the firm was formerly known as Immunis Holding Corp, undergoing a name change to Star8 Corporation in September 2010. Its corporate headquarters are located in Tsimshatsui, Hong Kong.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free